User profiles for Yee Hyung Kim
Yee Hyung KimKyung Hee University Verified email at khu.ac.kr Cited by 1703 |
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis
…, H Kim, OJ Kwon, YS Choi, K Kim, J Kim… - Clinical Infectious …, 2008 - academic.oup.com
Background. Multidrug-resistant (MDR) tuberculosis (TB) is more difficult to treat than is drug-susceptible
TB. To elucidate the optimal therapy for MDR TB, we assessed the treatment …
TB. To elucidate the optimal therapy for MDR TB, we assessed the treatment …
[HTML][HTML] The efficacy and safety of prone positioning in adults patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
…, SW Kim, SJ Lee, EK Kim, JH Kim, YH Kim… - Journal of thoracic …, 2015 - ncbi.nlm.nih.gov
Background Prone positioning for acute respiratory distress syndrome (ARDS) has no
impact on mortality despite significant improvements in oxygenation. However, a recent trial …
impact on mortality despite significant improvements in oxygenation. However, a recent trial …
[HTML][HTML] Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Background The ratio of neutrophils to lymphocytes (NLR) is a widely available marker of
inflammation. Several types of inflammatory cells and mediators have been found to be …
inflammation. Several types of inflammatory cells and mediators have been found to be …
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis
…, KU Kim, SB Choi, YJ Ryu, K Chan Kim… - American journal of …, 2013 - atsjournals.org
Rationale: Levofloxacin (LFX) and moxifloxacin (MXF) are the two most frequently recommended
fluoroquinolones for treatment of patients with multidrug-resistant tuberculosis (MDR-TB…
fluoroquinolones for treatment of patients with multidrug-resistant tuberculosis (MDR-TB…
Early bactericidal activity of delpazolid (LCB01-0371) in patients with pulmonary tuberculosis
JS Kim, Y Kim, SH Lee, YH Kim, J Kim… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Delpazolid, an oxazolidinone, has been studied in non-clinical studies of efficacy and toxicity
and Phase 1 clinical studies. Delpazolid has in vitro activity against Gram-positive bacteria, …
and Phase 1 clinical studies. Delpazolid has in vitro activity against Gram-positive bacteria, …
The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study
Background Uncontrolled diabetes, unlike controlled diabetes, is associated with an impaired
immune response. However, little is known about the impact of the status of diabetes …
immune response. However, little is known about the impact of the status of diabetes …
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based …
We evaluated whether ribonucleotide reductase regulatory subunit M1 (RRM1) protein
expression by immunohistochemistry (IHC) is a predictor of survival and response in gemcitabine-…
expression by immunohistochemistry (IHC) is a predictor of survival and response in gemcitabine-…
[HTML][HTML] Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study
The data regarding risk factors for death during tuberculosis (TB) treatment are inconsistent,
and few studies examined this issue in Korea. The purpose of this study was to evaluate …
and few studies examined this issue in Korea. The purpose of this study was to evaluate …
[HTML][HTML] Comparison of efficacy of intravenous peramivir and oral oseltamivir for the treatment of influenza: systematic review and meta-analysis
J Lee, JH Park, H Jwa, YH Kim - Yonsei Medical Journal, 2017 - ncbi.nlm.nih.gov
Purpose Peramivir is the first intravenously administered neuramidase inhibitor for immediate
delivery of an effective single-dose treatment in patients with influenza. However, limited …
delivery of an effective single-dose treatment in patients with influenza. However, limited …
[HTML][HTML] Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria
Although the treatment of pulmonary diseases due to nontuberculous mycobacteria (NTM)
requires the long-term use of antibiotics in combination, the treatment success rates are …
requires the long-term use of antibiotics in combination, the treatment success rates are …